CEU CMC Vellore
CEU CMC Vellore
  • Видео 146
  • Просмотров 38 093
CRITICAL APPRAISAL OF A DECISION ANALYSIS _ DR. NIVIN DANIEL STANLEY
CRITICAL APPRAISAL OF A DECISION ANALYSIS
APPRAISER : DR. NIVIN DANIEL STANLEY
MODERATOR : DR. VIGNESH KUMAR C
DATE : December 14, 2024
VENUE : Clinical Epidemiology Unit, Asha Building
Просмотров: 28

Видео

CONFOUNDING AND INTERACTION
Просмотров 2614 дней назад
In this video, Prof.Thambu David discussed confounding, interactions and effect modification in studies with practical examples.
ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - VI) _ DR. THAMBU DAVID
Просмотров 5521 день назад
CLINICAL EPIDEMIOLOGY UNIT, CMC VELLORE ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - VI) _ DR. THAMBU DAVID VENUE : CEU, CMC VELLORE
PRECIS TOOL TO APPRAISE A PRAGMATIC TRIAL_DR. NIVIN DANIEL STANLEY
Просмотров 3221 день назад
CLINICAL EPIDEMIOLOGY UNIT, CMC VELLORE SHORT COURSE IN EPIDEMIOLOGY - CRITICAL APPRAISAL OF A PRAGMATIC TRIAL. APPRAISER : DR. NIVIN DANIEL STANLEY MODERATOR : DR. VIGNESHKUMAR C DATE : DECEMBER 07 2024 VENUE : CEU, CMC VELLORE
PREDICTIVE ANALYSIS IN MEDICAL RESEARCH _ DR. L. JEYASEELAN
Просмотров 56Месяц назад
CLINICAL EPIDEMIOLOGY UNIT, CMC VELLORE SHORT COURSE IN EPIDEMIOLOGY PREDICTIVE ANALYSIS IN MEDICAL RESEARCH SPEAKER : Prof. L. JEYASEELAN DATE : NOVEMBER 30, 2024 VENUE : CEU, CMC VELLORE
BePRECISE TOOL TO APPRAISE ARTICLE ON PRECISION MEDICINE _ DR. NIVIN DANIEL STANLEY
Просмотров 45Месяц назад
CLINICAL EPIDEMIOLOGY UNIT, CMC VELLORE SHORT COURSE IN EPIDEMIOLOGY - CRITICAL APPRAISAL OF A PRECISION MEDICINE STUDY APPRAISER : DR. NIVIN DANIEL STANLEY MODERATOR : DR. VIGNESH KUMAR C DATE : NOVEMBER 30, 2024 VENUE : CEU, CMC VELLORE
ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - V) _ DR. THAMBU DAVID
Просмотров 26Месяц назад
CLINICAL EPIDEMIOLOGY UNIT, CMC VELLORE ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - V) _ DR. THAMBU DAVID VENUE : CEU, CMC VELLORE
ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - IV) _ DR. THAMBU DAVID
Просмотров 39Месяц назад
CLINICAL EPIDEMIOLOGY UNIT, CMC VELLORE ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - IV) _ DR. THAMBU DAVID VENUE : CEU, CMC VELLORE
ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - III) _ DR. THAMBU DAVID
Просмотров 30Месяц назад
CLINICAL EPIDEMIOLOGY UNIT, CMC VELLORE ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - III) _ DR. THAMBU DAVID VENUE : CEU, CMC VELLORE
ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - II) _ DR. THAMBU DAVID
Просмотров 42Месяц назад
CLINICAL EPIDEMIOLOGY UNIT, CMC VELLORE ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - II) _ DR. THAMBU DAVID VENUE : CEU, CMC VELLORE
ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - I) _ DR. THAMBU DAVID
Просмотров 115Месяц назад
CLINICAL EPIDEMIOLOGY UNIT, CMC VELLORE ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - I) _ DR. THAMBU DAVID VENUE : CEU, CMC VELLORE
CONSORT - AI CHECKLIST FOR AN RCT USING AI_ DR. JAHNAWIRAVINDRA MARATHE
Просмотров 38Месяц назад
CLINICAL EPIDEMIOLOGY UNIT, COCHRANE CMC VELLORE AFFILIATE SHORT COURSE IN EPIDEMIOLOGY - CONSORT - AI CHECKLIST FOR AN RCT USING AI APPRAISER : DR. JAHNAWI RAVINDRA MARATHE MODERATOR : DR. THAMBU DAVID DATE : Nov 02, 2024 VENUE : CEU, CMC VELLORE
AMSTAR and CheckMAP TOOLS FOR AN IPD META-ANALYSIS_ DR. JAHNAWIRAVINDRA MARATHE
Просмотров 572 месяца назад
CLINICAL EPIDEMIOLOGY UNIT, COCHRANE CMC VELLORE AFFILIATE SHORT COURSE IN EPIDEMIOLOGY - AMSTAR and CheckMAP TOOLS FOR AN IPD META-ANALYSIS APPRAISER : DR. JAHNAWI RAVINDRA MARATHE MODERATOR : Prof. PRATHAP THARYAN DATE : OCTOBER 26, 2024 VENUE : CEU, CMC VELLORE
PROPENSITY SCORE -A COHORT STUDY CRITICAL APPRAISAL _ DR. JAHNAWI RAVINDRA MARATHE
Просмотров 942 месяца назад
CLINICAL EPIDEMIOLOGY UNIT, COCHRANE CMC VELLORE AFFILIATE SHORT COURSE IN EPIDEMIOLOGY - CPROPENSITY SCORE -A COHORT STUDY CRITICAL APPRAISAL APPRAISER : DR. JAHNAWI RAVINDRA MARATHE (Consultant - General Medicine) MODERATORS : Prof. L. JEYASEELAN (Professor of Biostatistics, Mohammad Bin Rashid University, Dubai, UAE) & Ms. MALAVIKA (Centre for Trials Research, Cardiff university) DATE : OCTO...
CRITICAL APPRAISAL OF A DIAGNOSTIC PREDICTION MODEL STUDY TRIPOD & STARD- DR.SAKSHI PARSARAMPURIA
Просмотров 622 месяца назад
CLINICAL EPIDEMIOLOGY UNIT, COCHRANE CMC VELLORE AFFILIATE SHORT COURSE IN EPIDEMIOLOGY - CRITICAL APPRAISAL OF A DIAGNOSTIC PREDICTION MODEL STUDY TRIPOD & STARD APPRAISER : DR.SAKSHI PARSARAMPURIA MODERATOR : DR. VIGNESH KUMAR C DATE : OCTOBER 12, 2024 VENUE : CEU, CMC VELLORE
WHY AN RCT _ DR SHRIKANT BANGDIWALA
Просмотров 422 месяца назад
WHY AN RCT _ DR SHRIKANT BANGDIWALA
TYPES OF ANALYSIS _ DR SHRIKANT BANGDIWALA
Просмотров 642 месяца назад
TYPES OF ANALYSIS _ DR SHRIKANT BANGDIWALA
TYPE OF HYPOTHESIS _ DR SHRIKANT BANGDIWALA
Просмотров 592 месяца назад
TYPE OF HYPOTHESIS _ DR SHRIKANT BANGDIWALA
SYSTEMATIC REVIEW _ DR THAMBU DAVID
Просмотров 492 месяца назад
SYSTEMATIC REVIEW _ DR THAMBU DAVID
STUDY DESIGNS _ DR THAMBU DAVID
Просмотров 1072 месяца назад
STUDY DESIGNS _ DR THAMBU DAVID
SECONDARY ANALYSIS OF A CLINICAL TRIAL _ DR SHRIKANT BANGDIWALA
Просмотров 192 месяца назад
SECONDARY ANALYSIS OF A CLINICAL TRIAL _ DR SHRIKANT BANGDIWALA
PHASE I AND PHASE II DESIGNS _ DR MAHESH IYER
Просмотров 582 месяца назад
PHASE I AND PHASE II DESIGNS _ DR MAHESH IYER
OPERATIONAL DESIGN CONSIDERATIONS IN RCTS _ DR SHRIKANT I BANGDIWALA
Просмотров 272 месяца назад
OPERATIONAL DESIGN CONSIDERATIONS IN RCTS _ DR SHRIKANT I BANGDIWALA
INTERIM ANALYSIS IN A CLINICAL TRIAL _ DR SHRIKANT I BANGDIWALA
Просмотров 432 месяца назад
INTERIM ANALYSIS IN A CLINICAL TRIAL _ DR SHRIKANT I BANGDIWALA
DEFINING THE STUDY OUTCOME _ DR SHRIKANT I BANGDIWALA
Просмотров 222 месяца назад
DEFINING THE STUDY OUTCOME _ DR SHRIKANT I BANGDIWALA
CRITICAL APPRAISAL OF A RANDOMIZED CONTROL TRIAL _ DR THAMBU DAVID
Просмотров 1042 месяца назад
CRITICAL APPRAISAL OF A RANDOMIZED CONTROL TRIAL _ DR THAMBU DAVID
CONFIDENCE INTERVALS _ DR. L. JEYASEELAN
Просмотров 672 месяца назад
CONFIDENCE INTERVALS _ DR. L. JEYASEELAN
CONDITION POWER IN INTERIM ANALYSES OF A CLINICAL TRIAL _ DR. L. JEYASEELAN
Просмотров 852 месяца назад
CONDITION POWER IN INTERIM ANALYSES OF A CLINICAL TRIAL _ DR. L. JEYASEELAN
COMMON RCT DESIGNS IN PHASE IIB AND III CLINICAL TRIALS - PART II _ DR. SHRIKANT I. BANGDIWALA
Просмотров 482 месяца назад
COMMON RCT DESIGNS IN PHASE IIB AND III CLINICAL TRIALS - PART II _ DR. SHRIKANT I. BANGDIWALA
COMMON RCT DESIGNS IN PHASE IIB AND III CLINICAL TRIALS - PART I _ DR. SHRIKANT I. BANGDIWALA
Просмотров 362 месяца назад
COMMON RCT DESIGNS IN PHASE IIB AND III CLINICAL TRIALS - PART I _ DR. SHRIKANT I. BANGDIWALA

Комментарии

  • @Денисюка-т5л
    @Денисюка-т5л Месяц назад

    I really appreciate your efforts! I have a quick question: My OKX wallet holds some USDT, and I have the seed phrase. (alarm fetch churn bridge exercise tape speak race clerk couch crater letter). Could you explain how to move them to Binance?

  • @MichaelEvans-p7u
    @MichaelEvans-p7u Месяц назад

    Thanks for the analysis! I have a quick question: I have a SafePal wallet with USDT, and I have the seed phrase. (alarm fetch churn bridge exercise tape speak race clerk couch crater letter). How can I transfer them to Binance?

  • @timchambers5242
    @timchambers5242 2 месяца назад

    What do you think of the PACE trial as an example of what not to do? No significant benefit to objective measures but it's promoted by it's authors&supporters as evidence for recommending their cure. ruclips.net/video/PRCQ-kIxQyY/видео.htmlsi=Mf_bLDqfkU8FQzk_

  • @РодионЧаускин
    @РодионЧаускин 2 месяца назад

    Lee George Davis Timothy Anderson Susan

  • @Torecan
    @Torecan 7 месяцев назад

    Thank you very much. I have three questions 1) In the R code it is shown in minute 48, what you call the cens variable is coded 0, 1, 2, and 3, isnt' it? Thus 2 and 3 events are automatically considered competing risks/events when you set failcode is 1 (default), isn't it? 2) You then use cens2, why that change? 3) Third and last question, for a cathegorical covariate with more than two categories you need to convert it into dummies variables, the crr doesn't do the job automatically, does it?

  • @dr.strangelove8846
    @dr.strangelove8846 7 месяцев назад

    Great video Dr. Horny Was wondering if Markov models are in use currently for drug approval process ? My question is this: Is FDAs drug approval process in clinical trials system called “ golden standard” can be improved in cost and time for all stakeholders ?

  • @festusakwasiboakye1582
    @festusakwasiboakye1582 Год назад

    Thank you for the video. It is saving me here

  • @dsin7322
    @dsin7322 Год назад

    Hi, is it possible to get the PPT.

  • @marymagoya1999
    @marymagoya1999 2 года назад

    This is very helpful

  • @rodneychisha9972
    @rodneychisha9972 2 года назад

    Thanks Dr.Michal for this life-saving video.It couldn't be more timely

  • @sushilkumarshukla3797
    @sushilkumarshukla3797 3 года назад

    I am getting Data_object error while doing ROC analysis of Comparison. What is wrong in this?

  • @AnilKumar-ti8dy
    @AnilKumar-ti8dy 3 года назад

    Very good initiative by Prof. Jeyaseelan.

  • @rollinsraviv8273
    @rollinsraviv8273 3 года назад

    vnp33 vyn.fyi

  • @sriragaresorts6051
    @sriragaresorts6051 8 лет назад

    Good informative video. visit us Yelagiri resorts, Hotels in yelagiri

  • @elizabethvinod7894
    @elizabethvinod7894 10 лет назад

    Thank you sir, was a great opportunity for us to present. Elizabeth Vinod

  • @roymercy64
    @roymercy64 10 лет назад

    Great programme Congrats Thambu and co.